Tyber Medical Announces the Full Launch of TyFix™, An All-in-One Extremity System September 18, 2018 Bethlehem, Pennsylvania, February 28, 2018 – Tyber Medical, LLC, a privately held company focusing on developing innovative medical devices for private label opportunities and advancing the science of bioengineered surfaces, announces the launch of TyFix™, an all-in-one extremity joint fixation system. Tyber Medical is excited to announce the completion of the limited release for the TyFix™ System. Dr. Michael Gentile, DPM, FACFAS, at Cornell Surgery Center in Beaverton, OR, performed one of the first procedures utilizing the TyFix™ System. Dr. Gentile commented, “The instrumentation design is efficient and intuitive. A versatile implant with a myriad of sizes and angle options for a reliable fit and natural toe position.” The company received 510(k) clearance in July 2017 for the innovative system that reduces the need for ancillary instrumentation for a wide range of bone fixation procedures. The TyFix™ System, designed for a variety of procedures, including correction of Hammertoe deformities, allows realignment to relieve pain and discomfort. The integrated implant/instrument design, first of its kind, creates value by minimizing the number of procedure steps, improving operating room efficiency, and significantly reducing procedure time. In addition, the all-in-one sterile packed device eliminates traditional reprocessing costs. The TyFix™ screw combines a highly-optimized bone thread with a barbed head to maximize bone purchase and compression in both the proximal and distal phalanges. The system delivers intraoperative flexibility by offering solid and cannulated implants with diameters ranging from Ø1.5 – 4.0mm in multiple lengths as well as a straight and an angled 10o option. “The TyFix™ System is designed to deliver a construct at the speed of a k-wire and the holding strength of a screw, while also delivering an efficient OR process through the patented fully integrated implant and instrument design.” commented Jeff Tyber, CEO of Tyber Medical. He added, “Tyber Medical continues to focus and enhance our distal extremity platform, is dedicated to accelerating the path to market for our private label customers, and is always striving to add value through innovative solutions.” Visit Tyber Medical’s Booth #333, at ACFAS in Nashville, TN where the company will showcase the TyFix™ System as well as other innovative products available for private labeling. About Tyber Medical, LLC. Tyber Medical, LLC is an orthopedic device manufacturer providing rapid access to portfolio enhancing, regulatory approved, orthopedic implants within the spine and extremity/trauma markets. While focusing on rapid product commercialization, the company distributes products via private labeling; releasing 14 spine and 25 extremity/trauma systems since its founding in 2012. Tyber Medical utilizes the differentiated, bioengineered technology such as TyPEEK® osteoconductive coatings and BioTy™, a new antimicrobial nano-textured surface modification to enhance the company’s growing portfolio.